Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.12
BATS BZX Real-Time Price
As of 12:29pm ET
 -0.03 / -0.58%
Today’s Change
3.42
Today|||52-Week Range
6.31
+21.90%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 14.00 and a low estimate of 6.50. The median estimate represents a +66.02% increase from the last price of 5.12.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$7.5M
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.52%
 
 
 
 
 
 
Growthannually -7.76%
 
 
 
 
 
 

Sales

Growthquarterly -25.18%
 
 
 
 
 
 
Growthannually 112.30%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.